Uterine Hemostasis Colloquium II

May 8, 2019

Uterine Hemostasis Colloquium II
Preceding HTRS/NASTH 2019 Scientific Symposium Program Co-Chairs Andra H. James, MD, MPH and Kenneth G. Mann, PhD
Program Description: The meeting, a national colloquium of leading faculty/researchers/clinicians, reviewed our current understanding of the science as well as current evidence-based practice related to the diagnosis and clinical management of uterine hemostasis. It examined current knowledge and practice as applied to: 

  1. The role of complement in uterine hemorrhage.
  2. The role of inflammation in heavy menstrual bleeding (HMB).
  3. The use of Tranexamic Acid (TXA) in postpartum hemorrhage.
  4. The management of heavy menstrual bleeding (HMB) in women on anticoagulants.
  5. The latest in transfusion management in postpartum hemorrhage.
  6. Hemostatic challenges in pregnancy – Case-based discussion with Q & A with the audience.
Long-term impact: To improve the recognition of the role of uterine hemostasis in abnormal uterine bleeding, in postpartum hemorrhage and among women with bleeding disorders

Scroll down to view each presentation.

Day 1: Wednesday, May 8, 2019

Initial Welcome and Introduction Moderated by Andra H. James, MD, MPH and Kenneth G. Mann, PhD

Presentation 1: Role of Complement in Uterine Hemorrhage

Faculty: Gowthami Arepally, MD  

Presentation 2: The Role of Inflammation in Heavy Menstrual Bleeding

Faculty: Maureen Baldwin, MD, MPH

Presentation 2: Unanswered Questions in the Use of Tranexamic Acid (TXA) in Postpartum Hemorrhage

Faculty: Luis Pacheco, MD

Presentation 4: RFA Recipient: Sex Dimorphisms in Trauma-Induced Coagulopathy: A Mechanistic Exploration of a Sex-Specific Survival Benefit

Faculty: Julia Coleman, MD, MPH

Day 2: Thursday, May 9, 2019 

Presentation 5: Managing HMB in Women on AnticoagulantsFaculty: Sarah O’Brien, MD, MSc

Presentation 6: Latest in Management of Postpartum Hemorrhage

Faculty: Chad Grotegut, MD, MBA, MHSC

Presentations 7: Case-Based Discussion #1: Inherited AT Deficiency 

Faculty: Andra H. James, MD, MPH for (Ateefa Chaudhury, MD) 

Presentation 8: Case-Based Discussion #2: FXIII Deficiency and Pregnancy

Faculty: Rebecca Kruse-Jarres, MD, MPH

Presentation 9: Case-Based Discussion #3: Women with Hemophilia/Genetic Carrier 

Faculty: Robert Sidonio, Jr., MD, MSc